Free Cash Flow (Quarterly) Chart

Historical Free Cash Flow (Quarterly) Data

View and export this data back to 1998. Start Trial.
Date Value
June 30, 2026 19.20M
March 31, 2026 -22.14M
December 31, 2025 -5.591M
September 30, 2025 1.784M
June 30, 2025 -29.04M
March 31, 2025 -7.202M
December 31, 2024 -5.083M
September 30, 2024 -2.415M
June 30, 2024 -16.65M
March 31, 2024 16.48M
December 31, 2023 28.88M
September 30, 2023 -15.16M
June 30, 2023 -9.32M
March 31, 2023 -7.995M
December 31, 2022 -1.055M
September 30, 2022 17.84M
June 30, 2022 7.975M
March 31, 2022 -7.149M
December 31, 2021 3.809M
September 30, 2021 19.04M
June 30, 2021 2.858M
March 31, 2021 4.607M
December 31, 2020 17.40M
September 30, 2020 7.54M
June 30, 2020 -2.042M
Date Value
March 31, 2020 -10.36M
December 31, 2019 6.814M
September 30, 2019 9.226M
June 30, 2019 1.079M
March 31, 2019 -1.502M
December 31, 2018 1.821M
September 30, 2018 7.664M
June 30, 2018 -0.528M
March 31, 2018 1.565M
December 31, 2017 1.035M
September 30, 2017 2.759M
June 30, 2017 -1.049M
March 31, 2017 -0.938M
December 31, 2016 -0.303M
September 30, 2016 0.623M
June 30, 2016 1.509M
March 31, 2016 -3.985M
December 31, 2015 -2.607M
September 30, 2015 0.506M
June 30, 2015 0.431M
March 31, 2015 -2.537M
December 31, 2014 -5.06M
September 30, 2014 -0.612M
June 30, 2014 -2.325M
March 31, 2014 -4.008M

Free Cash Flow Definition

Free Cash Flow is the cash a company has left after paying for its day-to-day operations and investing in its physical assets, such as buildings, equipment and technology. The company can use that cash however it chooses: paying dividends, buying back shares, paying down debt, making acquisitions or keeping it for future growth.

Read full definition.

Free Cash Flow (Quarterly) Range, Past 5 Years

View Free Cash Flow (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Free Cash Flow (Quarterly) Benchmarks

View Free Cash Flow (Quarterly) Benchmarks
Start Trial
Intuitive Surgical, Inc. 948.40M
Enovis Corp. 31.14M
Stryker Corp. 1.059B
Zimmer Biomet Holdings, Inc. 246.00M
Edwards Lifesciences Corp. 585.00M